Stay updated with breaking news from Activating Construct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Acquisition includes HPN328, an investigational delta-like ligand 3 targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors ...
Investegate announcements from Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)
HARP | Complete Harpoon Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
19.12.2023 - SOUTH SAN FRANCISCO, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) - Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced abstract acceptance and an upcoming rapid oral ... Seite 1
SOUTH SAN FRANCISCO, Calif., Oct. 23, 2023 -- Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company developing novel T cell engagers, today announced that it has entered into a...